HTA Quarterly Late Summer 2017

By Xcenda

A look at medical nutrition reimbursement, severe asthma therapies, and Brazil's healthcare market.

Medical Nutritional Therapy

Achieving Reimbursement Across the Globe for Unique Non-drug Therapy Options

Medical nutritional therapy (MNT) is intended to meet specific nutritional requirements of a disease or condition that cannot be met by normal foods alone and should be used only under medical supervision. MNT can serve as the sole source of nourishment for prolonged periods, with balanced nutritional composition of macro- and micro-nutrients that reflect dietary recommendations. We examine the reimbursement landscape for this non-drug therapy option.

Therapeutic Spotlight

Biologic Treatments for Severe Asthma—a Paradigm Shift From Targeted to More Personalized Medicine

Patients with severe, uncontrolled asthma present special challenges both to clinicians and payers due to the extensive diagnostic evaluation required, insufficient evidence on the long-term outcomes of personalized treatment, and the burden on healthcare resources. We look at two injectable therapies that change the treatment landscape for severe or refractory asthma.

Emerging Markets

Brazil—The Largest Market in Latin America

Brazil was originally seen as one of the world’s strongest emerging markets when appointed the host country for the 2014 FIFA World Cup and the 2016 Olympic Summer Games. Unfortunately, the upward rise and growth of Brazil has been challenged since 2013 by increasing unemployment rates, rising inflation, and an economic recession. We examine this market, the largest in Latin America.